Alternatives to Laverock Therapeutics

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

Developing gene editing therapies to lower cholesterol.

Biotechnology company developing next-generation gene therapies using a proprietary protein splicing platform.

Engineering scalable gene therapies for broader patient populations.

Scalable, one-time curative in-vivo gene editing therapies.

Engineering-driven DNA design platform to overcome biological barriers in genetic medicines.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

A vertically-integrated procurement platform for the life sciences industry.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.

A biotechnology company developing genetic therapies for rare disorders.

A nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.

Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.

Pioneering vision restoration therapies for severe retinal degenerations.

AI-powered antibody discovery platform.

Developing ultrasound-mediated nonviral genetic medicines.

AI-native biotech company designing next-generation CAR T therapies for solid tumors.

Developing oral small molecule medicines for immunological and chronic diseases.

Developing novel therapies to reverse aging and extend lifespan.

Advancing next-generation mRNA medicines.

A biotechnology ecosystem company powering the future of drug discovery and development through AI-driven platforms and integrated services.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

Unlocking industrial-scale RNA-seq for primary drug screening and toxicology.

AI biologist platform accelerating preclinical drug development by integrating biological data for smarter decisions.

Advancing scalable microbiome-based therapeutics for severe and chronic diseases.

A biopharmaceutical company developing RNA interference (RNAi)-based medicines.

Decoding the immune system to pioneer a paradigm shift in disease diagnosis and treatment.

AI-enabled technology for cell biology research and biopharma development.

Space BioTech startup developing an autonomous, high-throughput screening platform for drug discovery in microgravity.

Developing precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis.

A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.

Biotech company developing novel drug delivery technologies.

Clinical-stage biotech company developing transformative cytokine therapies.

Advancing biopsy specimen stewardship and expanding access to precision oncology.

Biotechnology company defining membrane protein spatial relationships to create novel therapeutics for cancer and autoimmune diseases.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Biotechnology company developing new medicines for Parkinson's disease and other neurological disorders.

Developing an automated platform for liquid biopsy sample preparation.

Developer of spatial biology tools for life sciences research, now part of Bruker Spatial Biology.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Global supplier of life science research tools, including antibodies, reagents, and assays.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Enzyme-based technology to break down alcohol in the stomach.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

A global leader in clinical pharmacology and bioanalytical sciences.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.